TY - JOUR T1 - Passive Monitoring of Physiological Data and Self-reported Symptoms to Detect Clusters of People with COVID-19 JF - medRxiv DO - 10.1101/2020.07.06.20141333 SP - 2020.07.06.20141333 AU - Giorgio Quer AU - Jennifer M. Radin AU - Matteo Gadaleta AU - Katie Baca-Motes AU - Lauren Ariniello AU - Edward Ramos AU - Vik Kheterpal AU - Eric J. Topol AU - Steven R Steinhubl Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/07/2020.07.06.20141333.abstract N2 - Traditional screening for COVID-19 typically includes survey questions about symptoms, travel history, and sometimes temperature measurements. We explored whether longitudinal, personal sensor data can help identify subtle changes which may indicate an infection, such as COVID-19. To do this we developed an app that collects smartwatch and activity tracker data, as well as self-reported symptoms and diagnostic testing results from participants living in the US. We assessed whether symptoms and sensor data could differentiate COVID-19 positive versus negative cases in symptomatic individuals. Between March 25 and June 7, 2020, we enrolled 30,529 participants, of whom 3,811 reported symptoms, 54 reported testing positive for COVID-19, and 279 negative. We found that a combination of symptom and sensor data resulted in an AUC=0.80 [0.73 – 0.86] which was significantly better (p < 0.01) than a model which just considered symptoms alone (AUC=0.71 [0.63 – 0.79]) in the discrimination between symptomatic individuals positive or negative for COVID-19. Such orthogonal, continuous, passively captured data may be complementary to virus testing that is generally a one-off, or infrequent, sampling assay.Competing Interest StatementS.R.S. reports grants from Janssen and personal fees from Otsuka and Livongo, outside the submitted work. G.Q., J.M.R., M.G., K.B., L.A., E.R., V.K. and E.J.T. report no competing interests.Funding StatementThis work was supported by the National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences grant UL1TR001114.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol for this study was reviewed and approved by the Scripps Office for the Protection of Research Subjects. All individuals participating in the study provided informed consent electronically.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is an ongoing study. We plan to make the de-identified data widely available, we are currently working on a procedure to do it. ER -